# Pharmacia Diagnostics, Inc.

- Location (FDA's records): Columbia, MD
- FDA decisions: 10 (1990–2006): 10 510(k) clearances
- Names in FDA's records: Pharmacia Diagnostics, Inc. (7); Pharmacia Diagnostics AB (2); Pharmacia Diagnostics GmbH & Co. KG (1)
- Product codes: LGD (2), LFX (1), LFY (1), LFZ (1), JLX (1), MID (1), LJN (1), DHB (1), MST (1)
- Predicates its devices cite: 2 (0 its own); citations of its devices by later devices: 29 (0 its own)
- Recalls linked to its devices: 3 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Pharmacia, Inc.: 1 (https://510kreport.com/company/pharmacia)
- Pharmacia & Upjohn Co.: 1 (https://510kreport.com/company/pharmacia-upjohn)

## Firms that cite its devices most
- Phadia AB: 13 (https://510kreport.com/company/phadia)
- Hycor Biomedical, Inc.: 11 (https://510kreport.com/company/hycor-biomedical)
- Phadia US, Inc.: 3 (https://510kreport.com/company/phadia-us)
- Wallac OY: 2 (https://510kreport.com/company/wallac)

## Its most-cited devices
- K051218: Modification to:  Unicap Specific Ige (2005), cited by 27
- K912026: Delfia (R) 17 -OH-Progesteron Kit (1991), cited by 2

## Recent decisions
- K052793: Immunocap/Unicap Gliadin Iga, Immunocap/Unicap Specific Iga, Models 14-4425-40, 10-9306-02 (Feb 7, 2006)
- K051218: Modification to:  Unicap Specific Ige (Jun 9, 2005)
- K023433: Varelisa Cardiolipin Antibodies Screen, Models 15848 and 15896 (Nov 13, 2002)
- K921011: Pharmacia CMV Igm Elisa (Jul 27, 1992)
- K920702: Toxoplasma Gondii (Toxo) Igm Enzyme-Linked Immuno (Jul 8, 1992)
- K915348: Ebv-Vca Igm Elisa (Feb 14, 1992)
- K914022: Seriological Test Kit/Igm Antibody Vari-Zost Virus (Jan 27, 1992)
- K912026: Delfia (R) 17 -OH-Progesteron Kit (Jun 25, 1991)

Source page: https://510kreport.com/company/pharmacia-diagnostics